| 注册
首页|期刊导航|中国药理学通报|血管紧张素Ⅱ1型受体拮抗剂用于脓毒症大鼠的实验研究

血管紧张素Ⅱ1型受体拮抗剂用于脓毒症大鼠的实验研究

廖丽君 郭建荣 贾东林 喻君 沈华春

中国药理学通报2011,Vol.27Issue(10):1448-1451,4.
中国药理学通报2011,Vol.27Issue(10):1448-1451,4.DOI:10.3969/j.issn.1001-1978.2011.10.027

血管紧张素Ⅱ1型受体拮抗剂用于脓毒症大鼠的实验研究

Anti-inflammatory effect of losartan on LPS-induced sepsis in rats

廖丽君 1郭建荣 1贾东林 2喻君 3沈华春1

作者信息

  • 1. 宁波大学医学院附属李惠利医院麻醉科,浙江,宁波,315040
  • 2. 北京大学第三医院麻醉科,北京,100083
  • 3. 皖南医学院附属弋矶山医院麻醉科,安徽,芜湖,241001
  • 折叠

摘要

Abstract

Aim The purpose of this study was to investigate role of angiotensin Ⅱ 1 receptor ( ATIR ) antagonist on LPS-induced sepsis in rats.Methods Thirty male SD rats were randomly divided into 3groups ( n = 10 each ) , rats were injected with 9 mg ·ml-1 NaCl solution ( Control group ), or received LPS 12 mg · kg-1 intravenously ( LPS group ), or accepted infusion of an AT1 receptor antagonist , losartan 50 mg · kg-1 intraperitoneally 30 min before LPS 12 mg ·kg -1 was intravenously administered( LOS group ) .The plasma concentrations of nitric oxide ( NO ), malondialdehyde ( MDA ),IL-1β and TNF-α were measured in all rats 6 h after LPS administration, then all the rats were killed immediately before the aortas were removed and the inhibitor of NF-κB ( IKB ) mRNA and protein expressions in aortas were determined.Results The plasma concentrations of NO, MDA , IL-1β and TNF-α were all significantly elevated in LPS group compared with the control group ( P< 0.01 ), which were markedly reduced in LOS group ( P < 0.01 ).Both of the IκB mRNA and protein expressions in aortas were down-regulated after injection of LPS compared with the control group( P < 0.01 ).However, in the LOS group,IκB mRNA and protein expressions in aortas were obviously higher than the LPS group( P < 0.01 ).Conclusion AT1 receptor antagonist losartan exerts anti-inflammatory effects on sepsis rats.

关键词

脓毒症/血管紧张素Ⅱ1型受体/拮抗剂/内毒素/氯沙坦/IκB

Key words

sepsis/ angiotensin Ⅱ 1 receptor antagonist / antagonist / endotoxin / losartan / IκB

分类

医药卫生

引用本文复制引用

廖丽君,郭建荣,贾东林,喻君,沈华春..血管紧张素Ⅱ1型受体拮抗剂用于脓毒症大鼠的实验研究[J].中国药理学通报,2011,27(10):1448-1451,4.

基金项目

宁波市医学科技基金资助项目(No 200504) (No 200504)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量1
|
下载量0
段落导航相关论文